Navigate
RSS FeedInterested in linking to "Implementing PAT, One Step at a Time"?
You may use the Headline, Deck, Byline and URL of this article on your Web site. To link to this article, select and copy the HTML code below and paste it on your own Web site.
Implementing PAT, One Step at a Time
If FDA’s guidance and its risk-based inspection focus weren’t reason enough for pharma companies to implement Process Analytical Technology (PAT), its benefits in the areas of quality improvement, validation, manufacturing yield and efficiency, and reductions in inventory and overhead ought to spur increased adoption, urges Robert Cogdill, Ph.D., of Duquesne University's Center for Pharmaceutical Technology. Those who missed his presentation at Interphex last week can access it here.
By Robert Cogdill, Ph.D., Industrial Research Coordinator, Center for Pharmaceutical Technology, Duquesne University
To cast your vote, log in or become a member. This quick, one-time registration gives you access to members-only site benefits.
1 vote
Click the Download Now button below to access this 36-page (695 KB) PDF document.
To cast your vote, log in or become a member. This quick, one-time registration gives you access to members-only site benefits.
1 vote
PharmaManufacturing.com is the site for knowledge, news and analysis for manufacturing and other professionals working in the pharmaceutical, biopharmaceutical and biotech industries.